(Consolidated up to 63/2003)

ALBERTA REGULATION 21/99

Podiatry Act

DRUGS, CHEMICALS AND COMPOUNDS REGULATION

Purchase and supply of drugs

1(1)  A podiatrist may purchase and supply to his patients those drugs, chemicals and compounds that are

                                 (a)    intended for treatment of pathology of the feet, and

                                 (b)    not referred to in the Schedules to

                                           (i)    the Pharmaceutical Profession Act, or

                                          (ii)    the Food and Drugs Act (Canada).

(2)  Notwithstanding subsection (1)(b), a podiatrist may purchase and supply to his patients

                                 (a)    the analgesics listed in Schedule A;

                                 (b)    the antibiotics and anti‑fungal agents listed in Schedule B;

                                 (c)    the anti‑inflammatory agents listed in Schedule C;

                                 (d)    diphenhydramine;

                                 (e)    sucralfate;

                                  (f)    pentoxifylline.

(3)  Notwithstanding subsection (1)(b), a podiatrist may purchase and supply to his patients for use only in the presence of the podiatrist the drugs, chemicals and compounds listed in Schedule D.

Drugs under Pharmaceutical Profession Act

2(1)  A podiatrist who receives a certificate of approval for registration on or after June 3, 1993 may purchase, in addition to the drugs, chemicals and compounds authorized under section 1, the drugs referred to in the Schedules to the Pharmaceutical Profession Act.

(2)  A podiatrist who received a certificate of approval for registration before June 3, 1993 may purchase, in addition to the drugs, chemicals and compounds authorized under section 1, the drugs referred to in the Schedules to the Pharmaceutical Profession Act, on the completion of an upgrading program approved by the Board of Examiners in Podiatry.

(3)  A podiatrist who is authorized under this section to purchase drugs may supply those drugs only to patients of the podiatrist.

Expiry

3   For the purpose of ensuring that this Regulation is reviewed for ongoing relevancy and necessity, with the option that it may be repassed in its present or an amended form following a review, this Regulation expires on November 30, 2010.

AR 21/99 s3;63/2003

Schedule A

Ibuprofen Acid and its salts (Motrin)

Mefenamic Acid and its salts (Ponstan)

Ketorolac

Naproxen

Schedule B

Ampicillin and Griseofulvin

Other antibiotics and anti‑fungal agents as indicated and supported by sensitivity testing

Phisohex

Antibiotics and anti‑fungal agents for topical use

Schedule C

Betamethasone - 17 - Valerate

Flucinonide

Methylprednisolone

Triamcinolone-acetonide

Schedule D

Injectable steroids other than anabolic steroids

Tetanus antitoxin in accordance with the provincial immunization schedule

Diazepam

Lorazepam

Bleomycin